Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munir Alam

Showing results (101-110 of 206) with videos related to

Pageof 21
Sort By:
Clinical and Vaccine Immunology : CVI|August 18, 2017
Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant MacaquesBonnie Phillips, Genevieve G Fouda, Josh Eudailey, et al.
Plos Pathogens|June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.
The Journal of Experimental Medicine|November 12, 2020
Vi-specific serological correlates of protection for typhoid feverCelina Jin, Jennifer Hill, Bronwyn M Gunn, et al.
Viruses|October 28, 2015
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV VariantsPeter Hraber, Bette Korber, Kshitij Wagh, et al.
Ebiomedicine|August 20, 2015
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccineeNathan I Nicely, Kevin Wiehe, Thomas B Kepler, et al.
Journal of Virology|November 29, 2023
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variantsKan Li, Richard H C Huntwork, Gillian Q Horn, et al.
Frontiers in Immunology|March 6, 2023
A tool for evaluating heterogeneity in avidity of polyclonal antibodiesKan Li, Michael Dodds, Rachel L Spreng, et al.
Nature Communications|July 3, 2019
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformationsQifeng Han, Julia A Jones, Nathan I Nicely, et al.
Plos One|October 8, 2011
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sortingLynn Morris, Xi Chen, Munir Alam, et al.
Nature|November 16, 2012
Broad and potent neutralization of HIV-1 by a gp41-specific human antibodyJinghe Huang, Gilad Ofek, Leo Laub, et al.
Pageof 21

Showing results (101-110 of 206) with videos related to

Sort By:
Pageof 21
Clinical and Vaccine Immunology : CVI|August 18, 2017
Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant MacaquesBonnie Phillips, Genevieve G Fouda, Josh Eudailey, et al.
Plos Pathogens|June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.
The Journal of Experimental Medicine|November 12, 2020
Vi-specific serological correlates of protection for typhoid feverCelina Jin, Jennifer Hill, Bronwyn M Gunn, et al.
Viruses|October 28, 2015
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV VariantsPeter Hraber, Bette Korber, Kshitij Wagh, et al.
Ebiomedicine|August 20, 2015
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccineeNathan I Nicely, Kevin Wiehe, Thomas B Kepler, et al.
Journal of Virology|November 29, 2023
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variantsKan Li, Richard H C Huntwork, Gillian Q Horn, et al.
Frontiers in Immunology|March 6, 2023
A tool for evaluating heterogeneity in avidity of polyclonal antibodiesKan Li, Michael Dodds, Rachel L Spreng, et al.
Nature Communications|July 3, 2019
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformationsQifeng Han, Julia A Jones, Nathan I Nicely, et al.
Plos One|October 8, 2011
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sortingLynn Morris, Xi Chen, Munir Alam, et al.
Nature|November 16, 2012
Broad and potent neutralization of HIV-1 by a gp41-specific human antibodyJinghe Huang, Gilad Ofek, Leo Laub, et al.
Pageof 21